ha14-1 and apigenin
ha14-1 has been researched along with apigenin in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Banik, NL; Choudhury, SR; Davis, KA; Deeconda, A; Karmakar, S; Ray, SK | 1 |
Other Studies
1 other study(ies) available for ha14-1 and apigenin
| Article | Year |
|---|---|
Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways.
Topics: Antineoplastic Protocols; Apigenin; Apoptosis; Benzopyrans; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; ErbB Receptors; Humans; Neuroblastoma; Nitriles; Proto-Oncogene Proteins c-bcl-2; Vascular Endothelial Growth Factor A | 2009 |